Director of Biologics Drug Substance Development & Manufacturing

JOB TITLE : Director of Biologics Drug Substance Development & Manufacturing

DEPARTMENT : Technical Operations, Biologics

REPORTS TO : Sr. Director Biologics TechnicalDATE PREPARED : November 7, 2025

SUMMARY :

AVEO is seeking a Director of BDS Development who will lead all work associated with developing manufacturing processes and manufacturing BDS for clinical trial supply and process validation. The leader will oversee the team who is responsible to develop phase appropriate manufacturing processes at AVEO’s network of CDMO partners. Once developed, these processes will be transferred to a contract GMP manufacturing facility to produce BDS to support clinical trials. Additionally, the function will be responsible for process characterization work ahead of process validation and oversee the PPQ manufacturing at AVEO’s selected manufacturing partner.

PRINCIPLE DUTIES :

The Director of BDS Development will manage the team that works with the Process Development partner to ensure a robust, phase appropriate process is developed and transferred to the CMO for GMP manufacturing. Their team will be the technical stewards of the BDS manufacturing process and will oversee process development work from cell line development, upstream and downstream process development, cell bank generation, technology transfer, clinical manufacturing and process performance qualification (PPQ). They will prepare for and support commercial manufacturing as well as direct work for ongoing process improvements and gaining process efficiency to reduce cost of goods.

The incumbent will ideally have hands-on experience in one or more areas of cell line development, cell culture or purification development, and technology transfer. They will also have a clear understanding of phase appropriate GMP manufacturing and what is required for filing IND, IMPD and BLA dossiers.

• Strategic leadership of biologics drug substance team including resourcing, mentoring and team development; determining appropriate partners for performing development and GMP work, budgeting and managing financial metrics for the drug substance team (50%)
• Guide process development, technology transfer and manufacturing for clinical, process validation and commercial drug substance (20%)
• Lead process improvement work post validation to optimize, scale up and improve overall cost of goods (20%)
• Assume additional responsibilities as assigned and required .

REQUIRED QUALIFICATIONS / EXPERIENCE (BASIC QUALIFICATIONS) :

This job description is intended to describe the general nature and level of the work being performed by employees in the position.It is not intended to be a complete list of all responsibilities, duties, and skills for the position. The Company reserves the right at all times, in its sole discretion, to add or subtract duties and responsibilities, as it deems necessary.

About AVEO

AVEO is a commercial-stage, oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for patients with cancer. AVEO currently markets FOTIVDA® (tivozanib) in the U.S. for the treatment of adult patients with relapsed or refractory renal cell carcinoma (RCC) following two or more prior systemic therapies. AVEO continues to develop FOTIVDA in immuno-oncology combinations in RCC and other indications, and has several other investigational programs in clinical development. AVEO is committed to creating an environment of diversity, equity and inclusion to diversify representation within the Company.

All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, or status as a protected veteran.